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A B S T R A C T
Background: Asymptomatic bacteriuria (ABU) in antenatal women is microbiological diagnosis and if untreated have 20-30 
fold increased risk of developing pyelonephritis during pregnancy. Aim: The prospective study was conducted to determine 
the prevalence, risk factors and antibiotic resistance related to ABU in antenatal women. Subjects and Methods: A total of 
287 asymptomatic pregnant women who attended the antenatal clinic at a tertiary care hospital, Odisha, India from July 2012 
to December 2012 were enrolled. Two consecutively voided urine specimens were collected by clean-catch midstream urine 
technique for culture. The urine samples were processed and microbial isolates were identifi ed by conventional methods. 
Antimicrobial susceptibility testing was performed on all bacterial isolates by Kirby Bauer’s disc diff usion method. Data were 
analyzed using GraphPad Quick Calcs Statistical Software Inc., USA. Inferential statistics was done by Chi-square (2) test and a 
P < 0.05 was considered signifi cant. Results: The prevalence of ABU in antenatal women was 11.5% (33/287). Lower socio-economic 
status and low level of education were signifi cant risk factors related to ABU (P=0.02). Parity, maternal and gestational age was 
not signifi cantly associated with ABU. Escherichia coli (54.5%, 18/33) were the most prevalent isolate followed by Enterococcus 
faecalis (15.2%, 5/33). Nitrofurantoin was the most eff ective antibiotic, showed resistance rate of 3% (1/33) for both Gram-negative 
and Gram-positive bacteria. Conclusion: Routine screening using urine culture method should be performed for ABU in early 
pregnancy. Specifi c guidelines should be issued and followed for testing antimicrobial susceptibility with safe drugs in antenatal 
women. Empirical treatment with nitrofurantoin can be recommended, which is a safe drug and active for both Gram-negative 
and Gram-positive bacteria.
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INTRODUCTION
Urinary tract infection (UTI) during pregnancy is classified as 
either symptomatic or asymptomatic. Symptomatic UTI are 
divided into lower tract (acute cystitis) and upper tract (acute 
pyelonephritis) infection. Asymptomatic bacteriuria (ABU), 
generally defined as true bacteriuria in the absence of 
specific symptoms of acute UTI. The prevalence of ABU 
among antenatal women varies between 2% and 10%.[1] The 
anatomical and physiological changes imposed on urinary 
tract by pregnancy, as well as pressure on ureters by the 
gravid uterus and the muscle relaxant effect of progesterone, 
predisposes women with ABU to UTI.[2] Women identified 
with ABU in early pregnancy have 20-30 fold increased risk 
of developing pyelonephritis during pregnancy, compared 
with women without bacteriuria.[3] These women also are 
more likely to experience premature delivery and to have 
infants with low-birth weight.
Escherichia coli remains the single most common organism 
isolated from bacteriuric women, other organisms including 
Klebsiella pneumoniae, coagulase-negative Staphylococci, 
Enterococcus spp., group B Streptococci and Gardnerella 
vaginalis are common as well.[4] Gestational diabetes, 
past history of UTI, multiparity, advanced maternal age, 
advanced gestational age, lower education level and lower 
socio-economic status have been documented as risk 
factors in some of the studies and conflicting results have 
been obtained from different studies.[5,6]
Quantitative urine culture is the gold standard for diagnosis 
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that antimicrobial treatment of ABU during pregnancy 
decreases the risk of subsequent pyelonephritis from 20-30% 
to 1-4% and decreases the frequency of low-birth weight 
infants and preterm delivery.[7,8] Therefore, all antenatal 
women requires screening for bacteriuria by urine culture 
at least once in early pregnancy so that they can be treated 
with appropriate antibiotics for 3-7 days.[9] Antimicrobial 
agents including selective ß-lactams, nitrofurantoin, 
quinolones and co-trimoxazole can be considered during 
pregnancy.[10] However, the emergence of drug resistance, 
limits the choice of antibiotics.
To the best of our knowledge, no information is available 
from Odisha state, India on the prevalence of ABU in 
antenatal women. Hence, this prospective study was 
designed to determine the prevalence of ABU, etiological 
agents, risk factors and antimicrobial resistance patterns 




The present prospective study was carried out in the clinical 
Microbiology laboratory of a tertiary care hospital, which is 
located in southern Odisha, India. The duration of the study 
was 6 months period from July 2012 to December 2012.
Study popula  on
A total of 287 women in their first, second and third 
trimester of pregnancy, in the age group of 20-40 years 
who attended the antenatal clinic for the first time of our 
hospital were assessed for ABU. For asymptomatic pregnant 
women, bacteriuria is defined as two consecutive voided 
urine specimens with isolation of the same bacterial 
strain in quantitative counts ≥105 colony forming units 
per milliliter (cfu/mL).[9] Inclusion criteria included those 
pregnant women who consented to give two consecutive 
urine samples on the first antenatal visit. Exclusion 
criteria included: (a) Non-pregnant women, (b) signs and 
symptoms of UTI and (c) antibiotics usage within week. 
Demographic data, medical and social information as well 
as gynecological and obstetrics history of the subjects were 
obtained from pre-tested, self-administered questionnaire. 
The study was conducted after approval from Institutional 
Ethical Committee.
Sample collec  on and processing
On each antenatal visit, two consecutive freshly voided 
clean-catch midstream urine samples were collected from 
antenatal woman in a sterile wide mouth screw-capped 
universal container with aseptic precautions in the antenatal 
clinic. The specimens were labeled and transported to the 
microbiology laboratory for processing within 2 h.
Semi-quantitative urine culture was done using a calibrated 
loop. A loopful (0.001 mL) of well mixed un-centrifuged 
urine was inoculated onto the surface of cysteine lactose 
electrolyte deficient medium. The culture plates were 
incubated aerobically at 37°C for 18-24 h and count were 
expressed as cfu/mL. For this study, significant bacteriuria 
was defined as culture of a single bacterial species from 
two consecutive urine samples at a concentration of 
≥105 cfu/mL.[11] Only patients with significant bacteriuria 
(≥105 cfu/mL) were included for microbiological analysis. The 
culture isolates were identified by standard microbiological 
methods.[12] All culture media were procured from HiMedia 
Laboratories, Mumbai, India.
An  microbial suscep  bility tes  ng
Isolates were tested for antimicrobial susceptibility 
testing by the standard Kirby-Bauer disc diffusion method 
according to Bauer et al.[13] Mueller-Hinton agar plates 
were incubated for 24 h after inoculation with organisms 
and placement of discs. After 24 h the inhibition zones 
were measured. The following standard antibiotic discs for 
the isolates were used; ampicillin 10 micrograms (mcg), 
amoxicillin (10 mcg), amoxicillin/clavulinic acid (20/10 mcg), 
nitrofurantoin (300 mcg), cephalexin (30 mcg), cefuroxime 
(30 mcg) ciprofloxacin (5 mcg) and norfloxacin (10 mcg). 
Antibiotic discs were obtained from HiMedia Laboratories, 
Mumbai, India. The results were interpreted according to 
Clinical and Laboratory Standards Institute guidelines.[14] 
The quality control strains used were E. coli ATCC 25922 
and Enterococcus faecalis ATCC 29212 for antimicrobial 
discs.
Sta  s  cal analysis
The data were analyzed using GraphPad Quick Calcs 
Statistical Software Inc., USA. Inferential statistics was 
done by Chi-square (2) test and a P < 0.05 was considered 
significant.
RESULTS
The mean age of antenatal women who attended antenatal 
clinic and participated the study was 25.87 (5.2) years 
(median 24, minimum 20 and maximum 40 years). Out of 
total 287 antenatal women examined for ABU, 33 were 
positive for significant bacteriuria; thus showed a prevalence 
of 11.5% (33/287).
Table 1 shows the socio-economic characteristics of the study 
subjects by age, level of education, socio-economic status, 
estimated gestational age and parity. Majority (241/287,84%) 
of subjects were between the age group of 20 and 
30 years, showed a prevalence of 11.2%(27/241). Similarly, 
majority (54.4%, 156/287) of the subjects were multipara 
and presented in 2nd and 3rd trimester of pregnancy (61%, 
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175/287), had revealed prevalence of 14.1% (22/156) and 
14.3% (25/175) respectively. These variables did not show 
statistically significant results. Evaluation of significant 
bacteriuria in relation to the level of education and 
socio-economic status showed significant association with 
low level of education and lower socio-economic status.
The frequency of microorganisms isolated is shown in 
Table 2. From total 33 significant bacteriuria isolates, 
Gram-negative bacteria accounted for 69.7% (23/33), while 
Gram-positive bacteria accounted for 30.3%(10/33). E. coli 
(54.5%, 18/33) was the most frequently isolated bacteria, 
followed by E. faecalis (15.2%, 5/33), The antibiotic resistance 
profiles of the bacterial isolates are summarized in Table 3. 
Overall, Gram-negative isolates showed higher resistance 
pattern in comparison to Gram-positive. Nitrofurantoin was 
the most effective antibiotic for both Gram-negative and 
Gram-positive bacteria, showed resistance rate of 3% (1/33), 
followed by ciprofloxacin 30.3% (10/33) and amoxicillin/
clavulinic acid 36.4% (12/33).
DISCUSSION
ABU in antenatal women is a microbiologic diagnosis 
determined with a gold standard urine culture for significant 
bacteriuria during their 1st antenatal visit preferably at 
the end of 1st trimester.[10] This present study provides 
valuable laboratory data to know the prevalence of ABU 
among antenatal women, to study their socio-demographic 
profiles, to monitor the status of antibiotic resistance in 
uropathogens and to improve treatment recommendations 
in a specific geographic region. This study also allows 
comparison of the situation in Odisha state with other 
regions within and outside India.
From total 287 urine samples collected from asymptomatic 
antenatal women and tested, 33 yielded significant 
uropathogens thus showed a prevalence of 11.5% (33/287). 
This correlates with the global prevalence of ABU among 
antenatal women, which varies between 2% and 10%. Similar 
prevalence of ABU 9.8%, 11.2%, 13.7% and 16% among antenatal 
women was reported by Marahatta et al. in Kathmandu, 
Nepal, Chitralekha et al. in Chennai, India, Saeed and Tariq 
in Karachi, Pakistan and Ansari and Rajkumari in Hyderabad, 
India respectively.[15-18] Low prevalence rate of 6.1% and 7.5% 
was observed by Ahmad et al. in Kashmir, India and Saraswathi 
and Aljabri in Hyderabad, India.[19,20] High prevalence of 29.1%, 
38.3% and 45.3% was revealed by Rahimkhani et al. in Tehran, 
Iran, Rizvi et al. in Aligarh, India and Imade et al. in Benin city, 
Edo state, Nigeria respectively.[21-23] Geographical location 
and varied distribution of microorganisms may be the reason 
for this wide difference in prevalence.
In our study, majority of the bacteriuric women belonged 
to lower socio-economic status and they studied up to 
primary level. The ABU was significantly associated among 
them (P < 0.05). The close association between ABU, low 
socio-economic status and low level of education has been 
documented by various researchers.[24-27] This association 
may be due to poor knowledge and practice of personal 
hygiene in pregnancy. Another reason could be as a result 
of poor genital hygiene practices by antenatal women 
who may find it difficult to clean their anus properly after 
defecating or clean their genital after passing urine.[23]
Table 1: Socio-demographic characteristics by the distribution of study subjects
Variables Total no. of urine specimen collected from antenatal women Chi-square value P value
No. tested (%) UTI absent (%) UTI present (%)
Age in years
20-30 years 241 (84) 214 (88.8) 27 (11.2) 0.01 0.91
31-40 years 46 (16) 40 (87) 06 (13) (NS)
Level of education
Up to primary level 195 (67.9) 167 (85.6) 28 (14.4) 4.05 0.04
College and higher 92 (32.1) 87 (94.6) 05 (5.4) (S)
Socio-economic status
Low 179 (62.4) 152 (84.9) 27 (15.1) 5.11 0.02
High 108 (37.6) 102 (94.4) 06 (5.6) (S)
Gestational age
<13 weeks (1st trimester) 112 (39) 104 (92.9) 08 (7.1) 2.76 0.09
≥13 weeks (2nd and 3rd trimester) 175 (61) 150 (85.7) 25 (14.3) (NS)
Parity
Primigravida 131 (45.6) 120 (91.6) 11 (8.4) 1.75 0.18
Multipara 156 (54.4) 134 (85.9) 22 (14.1) (NS)
UTI – Urinary tract infection;  P<0.05 (statistically signifi cant); S – Signifi cant; NS – Not signifi cant; (n=287)
Table 2: Prevalence of uropathogens among asymptomatic 
antenatal women in a tertiary care hospital, Odisha, India
Gram reaction Microorganism Number Percentage
Gram-negative bacteria Escherichia coli 18 54.5
Klebsiella pneumoniae 02 6.1
Citrobacter freundii 02 6.1
Proteus mirabilis 01 3
Gram-positive bacteria Enterococcus faecalis 05 15.2
Staphylococcus saprophyticus 04 12.1
Staphylococcus epidermidis 01 3
Total number of bacteria 
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In the present study, prevalence of 11.2% was recorded in 
the age group of 20-30 years and 13% among 31-40 age 
groups. No relationship between prevalence of ABU and 
patient’s age group was found (P = 0.91). Similar findings 
were obtained in previous studies.[24,26,28] Advanced maternal 
age (≥35 years) was reported as risk factor for ABU in 
pregnancy.[5]
There was no significant difference in the prevalence of ABU 
with respect to trimester and parity in our study (P = 0.09 
and 0.18 respectively). This agrees with earlier studies.[23,27] 
It has been reported that advanced gestational age and 
multipara are risk factors for acquiring ABU in pregnancy.[18,24]
In our study, Gram-negative aerobic bacteria predominated 
(69.7%), among which E. coli was the most prevalent 
uropathogens, followed by E. faecalis (15.2%) and 
S. saprophyticus (12.1%). There is increase in prevalence of 
Enterococcus spp. and S. saprophyticus have been reported 
by various authors in different studies.[21,29-31] The data 
collected from different places around the world showed 
that E. coli and Klebsiella spp. are still commonest pathogens 
in ABU.[15,16,19,22] Gram-negative aerobic bacteria including 
Enterobacteriaceae have several factors responsible for 
their attachment to uroepithelium. They colonize in the 
urogenital mucosa with adhesin, pili, fimbriae and P-1 blood 
group phenotype receptor.[32]
Treatment of ABU has been shown to reduce the rate of 
pyelonephritis in later part of pregnancy and therefore 
regular screening for and appropriate treatment of 
ABU has become a standard of obstetrical care.[33] The 
antibiotic chosen for antenatal women should have 
a good maternal and fetal safety profile, excellent 
efficacy and low resistance rate. United States food 
and drug administration, category B drugs including 
ampicillin, amoxicillin, amoxicillin/clavulinic acid, 
cephalexin, cefuroxime and nitrofurantoin and category 
C drugs including ciprofloxacin, norfloxacin, levofloxacin 
and co-trimoxazole should be used as empirical 
therapy for both ABU and symptomatic UTI during 
pregnancy.[10] However, local antibiotic susceptibility 
patterns must be taken into account before choosing an 
agent due to increasing antibiotic resistance prevalent 
for the population in question. In this present study, 
Gram-negative isolates showed higher resistance pattern 
in comparison to Gram-positive isolates. Gram-negative 
isolates including E. coli showed high level of resistance 
pattern to ampicillin, amoxicillin, norfloxacin, cephalexin, 
cefuroxime, amoxicillin/clavulinic acid and ciprofloxacin. 
Nitrofurantoin was found to be single most effective drug 
for both Gram-negative and Gram-positive bacteria, showed 
resistant rate of 3%. Similar resistance pattern was reported 
from studies conducted in different parts of India and its 
neighboring countries.[15,30,31,34] Irrational prescription of 
antibiotics which are available over-the-counter in India 
and indiscriminate use has created has created a high 
level of drug resistance. Our findings thus suggest that 
empirical treatment with commonly used antibiotics 
except nitrofurantoin should no longer be appropriate.
This study was limited by less sample size and some of the 
study subjects attended antenatal clinic late, i.e., in their 2nd 
and 3rd trimester of pregnancy was included.
CONCLUSION
Our study showed prevalence rate of ABU among antenatal 
women was 11.5%. Nitrofurantoin was the most effective 
antibiotic for both Gram-negative and Gram-positive 
bacteria with resistance rate of <10%. Therefore, it 
is important to screen all antenatal women with gold 
standard urine culture for significant bacteriuria during 
their 1st antenatal visit preferably at the end of 1st trimester. 
This should be followed with antibiotic susceptibility for 
determining therapy as inappropriate or no therapy has 
been responsible for recurrences of ABU and subsequent 
development of acute pyelonephritis. Thus empirical 
treatment of ABU may not apply for specific geographical 
regions, where decreased susceptibility rates to commonly 
used antibiotics have been documented for uropathogens.
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